# Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes

> **NCT00377676** · PHASE3 · COMPLETED · sponsor: **VeroScience** · enrollment: 3095 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Cycloset
- **DRUG:** Usual Diabetes Therapy plus placebo

## Key facts

- **NCT ID:** NCT00377676
- **Lead sponsor:** VeroScience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 3095 (ACTUAL)
- **Last updated:** 2016-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377676, "Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00377676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*